Contents

Search


meningococcal groups ABCWY vaccine (Penbraya)

Indications: - prevention of 5 most common serotypes* of meningococcal meningitis in children & young adults age 10-25 years * serotypes A, B C, W-135, & Y

General

meningococcal vaccine

References

  1. FDA Approves PENBRAYA, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents. Businesswire, Oct 20, 2013 https://www.businesswire.com/news/home/20231019164717/en/FDA-Approves-PENBRAYA%E2%84%A2-the-First-and-Only-Vaccine-for-the-Prevention-of-the-Five-Most-Common-Serogroups-Causing-Meningococcal-Disease-in-Adolescents - Owens B New Meningococcal Vaccine Wins FDA Approval. Medscape. Oct 23, 2023 https://www.medscape.com/viewarticle/997636